傳染病|Quest Diagnostics. - ld乐动官方入口,LD乐动体育米兰官方

When a patient has a complex or chronic infection, care planning often requires convenient, easy specimen collection, comprehensive testing, and extensive support. With flexible tests and screens for a wide range of diseases, Quest Diagnostics provides you the actionable insights that help you provide the best care possible.

\r\n

From hepatitis and tuberculosis (TB) to human immunodeficiency virus (HIV), tick-borne disease, and other infections, our testing menu is both diverse and innovative, accounting for resistant organisms and newly emerging strains of some of the most dangerous pathogens. You can also count on our suite of integrated services—including patient reminders and appointment scheduling—to optimize compliance during monitoring, treatment, and follow-up.
\r\n

\r\n","@type":"corporate/components/text"}}" id="text-fc9034694d" class="cmp-text">

當患者具有複雜或慢性感染時，護理計劃通常需要方便，簡單的標本收集，全麵的測試和廣泛的支持。對於廣泛的疾病的靈活測試和屏幕，Quest Diagnostics為您提供可操作的見解，幫助您提供最佳護理。

從肝炎和結核病（TB）到人免疫缺陷病毒（HIV），蜱傳疾病和其他感染，我們的測試菜單都是多種多樣的，抗性生物和新出現的一些最危險病原體的菌株。您還可以依靠我們的綜合服務套件 - 包括患者提醒和預約調度 - 在監測，治療和隨訪期間優化合規性。

Adaptive測試程序在Covid-19中出現

The pandemic exposed the challenges and opportunities in enabling faster and more effective diagnostics for infectious diseases. While vaccines have helped to significantly mitigate the transmission of COVID-19, new variants have proven to be particularly problematic among unvaccinated individuals and high-risk communities.

\r\n

As these and other barriers take shape during the return to work, school, life, and healthcare, the need for comprehensive, flexible, and adaptive testing programs is evident. While COVID-19 has taken priority, the lessons learned from the pandemic also bring new insights for prevention, diagnosis, and management of future epidemics.

\r\n","@type":"corporate/components/text"}}" id="text-1fdb444ce6" class="cmp-text">

大流行暴露了支持的挑戰和機遇更快，更有效的診斷對於傳染病。疫苗有助於顯著減輕Covid-19的傳播，而新的變體已被證明在未接觸的個人和高風險社區之間特別有問題。

隨著這些和其他障礙在返回工作期間造成的障礙，學校，生活和醫療保健，需要全麵，靈活，自適應測試計劃是顯而易見的。雖然Covid-19已經優先考慮，但從大流行中汲取的經驗教訓也為未來流行病的預防，診斷和管理帶來了新的見解。

全麵的測試範圍

Make more informed, confident diagnostic and treatment decisions relying on our extensive infectious disease test menu. Our quantitative and qualitative assays help physicians not only screen for and identify pathogens, but help in assessing treatment response and drug resistance, and in planning appropriate care.

\r\n","@type":"corporate/components/text"}}" id="text-d6b1021edf" class="cmp-text">

依賴於我們廣泛的傳染病測試菜單製定更明智的，自信的診斷和治療決策。我們的定量和定性測定不僅可以篩選和鑒定病原體，而且有助於評估治療反應和耐藥性，以及規劃適當的護理。

","@type":"corporate/components/container"}}" id="accordion-50120654b2-item-4c49853da1">

與全麵的A-E測試打擊肝炎

In the United States, viral hepatitis cases continue to climb, disproportionately affecting younger patients and vulnerable communities. Many people are unaware of their infection, making screening even more vital. If left untreated, hepatitis can lead to adverse outcomes, from cirrhosis to liver cancer. Our extensive screening options, seamless results reporting, and clinical expertise are all designed to help you and your patients identify and manage hepatitis at every stage.

\r\n","@type":"corporate/components/text"}}" id="text-dfaad91712" class="cmp-text">

在美國，病毒肝炎病例繼續攀升，不成比例地影響年輕的患者和弱勢社區。許多人都沒有意識到他們的感染，使篩查更加重要。如果未經處理過的話，肝炎會導致不良結果，從肝硬化到肝癌。我們廣泛的篩選選項，無縫結果報告和臨床專業知識均旨在幫助您和您的患者在每個階段確定和管理肝炎。

查看所有肝炎測試

為艾滋病毒的每個階段測定

Our HIV-1 treatment and monitoring menu offers a full array of tests for determining HIV-1 subtype, assessing antiretroviral drug resistance, and selecting the appropriate treatment. With assays for all stages of disease, we help you support your patients throughout their care journey, from prevention and screening to monitoring treatments.

\r\n","@type":"corporate/components/text"}}" id="text-03022d0639" class="cmp-text">

我們的HIV-1治療和監測菜單提供了一種用於確定HIV-1亞型，評估抗逆轉錄病毒耐藥性，並選擇適當的治療的全陣列測試。對於所有疾病階段的測定，我們幫助您在整個護理旅程中支持您的患者，從預防和篩選到監測治療。

查看所有HIV測試

","@type":"corporate/components/container"}}" id="accordion-50120654b2-item-1e461ef232">

測試結核病的更好方法

Screening for latent TB is important for many patient populations, including those initiating biologic/biosimilar therapy, migrant workers, healthcare personnel, and school-aged children, among others. The challenge is that standard skin screens can lead to false positives, lost time, and higher costs associated with follow-up testing. Choose the better way to test, especially in cases where latent TB may be suspected. Get insights only a blood test can yield—easily performed in one visit, with one tube.
\r\n

\r\n

Tuberculosis tests:

\r\n","@type":"corporate/components/text"}}" id="text-3ad1cf0eb1" class="cmp-text">

對潛伏結核病的篩查對於許多患者群體是重要的，包括啟動生物學/生物仿製性療法，移民工人，醫療保健人員和學齡兒童等的人。挑戰是標準的皮膚屏幕可以導致誤報，損失和與隨訪測試相關的更高的成本。選擇更好的測試方法，特別是在可能懷疑潛在結核病的情況下。隻有血液測試就可以在一次訪問中輕鬆進行驗血，隻有一個管。

結核病試驗：

T-Spot^®。TB.

Quantiferon.^®-tb gold plus，4個管，灌溉網站孵化

Quantiferon.^®-tb gold plus，1管

具有反射和QFT 4管的Pre-Biologic / BioSimilar屏幕麵板，HCV / HBV

具有反應和QFT 1管的PRE-BIOLIC / BIOSIMILAR屏幕麵板，HCV / HBV

\r\n","@type":"corporate/components/container"}}" id="accordion-50120654b2-item-74621133b7">

正確診斷的有效途徑

For seasonal acute respiratory tract infections, timely clinical decision-making is crucial. Molecular respiratory syndromic panels from Quest Diagnostics provide accurate, rapid, reliable results so that you can start the appropriate treatment sooner while maintaining antibiotic stewardship.
\r\n

\r\n

\r\n","@type":"corporate/components/text"}}" id="text-f124efb97e" class="cmp-text">

對於季節性急性呼吸道感染，及時的臨床決策至關重要。Quest Diagnostics的分子呼吸道綜合征麵板提供準確，快速，可靠的結果，以便您可以在保持抗生素管理的同時開始適當的治療方法。

Cotesting for differential diagnosis of SARS-CoV-2 (COVID-19) and other common respiratory pathogens using a single specimen:

\r\n","@type":"corporate/components/text"}}" id="text-a32e34e69b" class="cmp-text">

Cotesting用於使用單個標本的SARS-COV-2（Covid-19）和其他常見呼吸道病原體的鑒別診斷：

SARS-COV-2 RNA，流感A / B和RSV RNA，定性Naat

SARS-COV-2 RNA（Covid-19）和流感A和B，定性Naat

SARS-COV-2 RNA（Covid-19）和呼吸道病毒板，定性Naat

SARS-COV-2 RNA（Covid-19）和呼吸道病原體麵板，定性Naat

\r\nInfluenza A/B and RSV tests:

\r\n","@type":"corporate/components/text"}}" id="text-608d3c7bed" class="cmp-text">

流感A / B和RSV測試：

流感A和B RNA，定性RT-PCR

呼吸合胞病毒（RSV）RNA，定性實時PCR

流感A和B和RSV RNA，定性，實時RT-PCR

\r\nSARS-CoV-2 (COVID-19) tests:

\r\n","@type":"corporate/components/text"}}" id="text-daa7f6ea33" class="cmp-text">

SARS-COV-2（Covid-19）測試：

查看所有Covid-19測試

\r\n Respiratory panels/profiles:

\r\n","@type":"corporate/components/text"}}" id="text-f65f5df448" class="cmp-text">

呼吸麵板/型材：

RVP.

rpp.

","@type":"corporate/components/container"}}" id="accordion-50120654b2-item-c4f3a31d34">

您需要的所有工具

Patients with vector-borne diseases can deteriorate quickly, but early detection mitigates complications. Quest Diagnostics offers convenient, one-visit screening solutions that can detect infections, including Lyme disease, Zika virus, malaria, and others, whether latent or not.

\r\n

Vector-borne disease tests:

\r\n","@type":"corporate/components/text"}}" id="text-e9ea433e9e" class="cmp-text">

患有載體傳播疾病的患者可能會迅速惡化，但早期檢測緩解並發症。Quest Diagnostics提供方便，一次訪問篩查解決方案，可檢測感染，包括萊姆病，Zika病毒，瘧疾等，無論是否潛在。

載體傳播疾病測試：